We are live on ! Find out more
BA

BlackRock Advisors Portfolio holdings

AUM $98.8B
1-Year Est. Return 15.8%
This Fund
S&P 500
This Quarter Est. Return
-7.26%
1 Year Est. Return
+15.8%
3 Year Est. Return
+32.35%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$93.3B
AUM Growth
-$2.89B
Cap. Flow
+$5.74B
Cap. Flow %
6.15%
Top 10 Hldgs %
15.28%
Holding
3,878
New
163
Increased
1,568
Reduced
1,679
Closed
111

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$423M
2
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$367M
3
XOM icon
ExxonMobil
XOM
+$337M
4
JNJ icon
Johnson & Johnson
JNJ
+$257M
5
BIIB icon
Biogen
BIIB
+$250M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$195M
2
ABBV icon
AbbVie
ABBV
+$188M
3
JPM icon
JPMorgan Chase
JPM
+$183M
4
BMY icon
Bristol-Myers Squibb
BMY
+$176M
5
TEVA icon
Teva Pharmaceuticals
TEVA
+$174M

Sector Composition

Rank Sector Weight
1 Healthcare 18.49%
2 Financials 16.75%
3 Technology 9.99%
4 Industrials 8.32%
5 Energy 7.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IIN
3476
DELISTED
IntriCon Corporation
IIN
$22K ﹤0.01%
2,740
– –
QADB
3477
DELISTED
QAD Inc. Class B
QADB
$22K ﹤0.01%
1,021
– –
LEAF
3478
DELISTED
Leaf Group Ltd.
LEAF
$22K ﹤0.01%
5,191
+4,515
+668% +$23.1K
IVTY
3479
DELISTED
Invuity, Inc
IVTY
$22K ﹤0.01%
+1,562
New +$20.5K
FSAM
3480
DELISTED
Fifth Street Asset Management Inc. Class A
FSAM
$22K ﹤0.01%
2,951
+81
+3% +$707
NAME
3481
DELISTED
Rightside Group, Ltd.
NAME
$22K ﹤0.01%
2,809
+759
+37% +$5.44K
CIFC
3482
DELISTED
CIFC LLC Common Shares
CIFC
$22K ﹤0.01%
3,012
– –
ABEO icon
3483
Abeona Therapeutics
ABEO
$345M
$21K ﹤0.01%
210
+5
+2% +$664
AP icon
3484
Ampco-Pittsburgh
AP
$167M
$21K ﹤0.01%
1,955
+553
+39% +$7.01K
FATE icon
3485
Fate Therapeutics
FATE
$281M
$21K ﹤0.01%
4,030
+2,862
+245% +$19.5K
MT icon
3486
PUT
ArcelorMittal
MT
$50.4B
$21K ﹤0.01%
+1,749
New +$32.5K
PALI icon
3487
Palisade Bio
PALI
$339M
– –
0
– –
PHG icon
3488
Philips
PHG
$25.4B
$21K ﹤0.01%
+1,257
New +$23.4K
TLPH icon
3489
Talphera
TLPH
$70.1M
$21K ﹤0.01%
350
+107
+44% +$8.79K
UBFO
3490
DELISTED
United Security Bancshares
UBFO
$21K ﹤0.01%
4,217
-1
-0% -$5
CIVB icon
3491
Civista Bancshares
CIVB
$594M
$20K ﹤0.01%
1,968
– –
CVU icon
3492
CPI Aerostructures
CVU
$62.2M
$20K ﹤0.01%
2,281
– –
FUNC icon
3493
First United
FUNC
$288M
$20K ﹤0.01%
2,396
+612
+34% +$5.07K
IESC icon
3494
IES Holdings
IESC
$12.5B
$20K ﹤0.01%
2,641
– –
LFVN icon
3495
LifeVantage
LFVN
$82.4M
$20K ﹤0.01%
3,491
– –
HWCC
3496
DELISTED
Houston Wire & Cable Company
HWCC
$20K ﹤0.01%
3,110
– –
ZN
3497
DELISTED
Zion Oil & Gas, Inc.
ZN
$20K ﹤0.01%
14,230
– –
AST
3498
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$20K ﹤0.01%
5,229
– –
ACNT icon
3499
Ascent Industries
ACNT
$137M
$19K ﹤0.01%
2,147
– –
ALT icon
3500
Altimmune
ALT
$539M
$19K ﹤0.01%
48
– –
138 139
140
141 142

Similar funds

BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return
BJ
BlackRock Japan Tokyo, Japan $30.3B AUM 13.85% 1-Year Est. Return
IC
Institutional Capital Chicago, Illinois $6.75B AUM 3.44% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return
MFS
MSI Financial Services Springfield, Massachusetts $3.07B AUM 10.22% 1-Year Est. Return
CIM
Calvert Investment Management Bethesda, Maryland $2.67B AUM 16.23% 1-Year Est. Return
KAM
Keeley Asset Management Chicago, Illinois $2.35B AUM 26.92% 1-Year Est. Return
PFM
PacWest Financial Management Phoenix, Arizona $1.69B AUM 8.84% 1-Year Est. Return

BlackRock Advisors's Q3 2015 Portfolio in Review

As of Q3 2015, BlackRock Advisors held 3,878 positions worth $93.3B, down 3% from $96.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

BlackRock Advisors deployed $5.74B of net new capital in Q3 2015, opening 163 new positions and adding to 1,568 existing holdings. Its largest new stake was Allergan plc: 186,940 shares worth $176M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 20% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $195M trimmed.

  • BlackRock Advisors's largest Q3 2015 buy was Allergan plc: 186,940 shares worth $176M.
  • BlackRock Advisors added most to Apple in Q3 2015, an estimated $423M increase.
  • BlackRock Advisors's biggest Q3 2015 reduction was Vertex Pharmaceuticals, cutting an estimated $195M.
  • BlackRock Advisors fully exited RECEPTOS INC COM STK (DE) in Q3 2015, selling an estimated $108M.
  • BlackRock Advisors's ten largest holdings make up 15% of its $93.3B portfolio in Q3 2015.
  • BlackRock Advisors opened 163 new positions and closed 111 in Q3 2015.
  • BlackRock Advisors's portfolio value fell 3% quarter-over-quarter to $93.3B.

Based on BlackRock Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.